This week's Hong Kong stock IPO highlights, currently the hottest, are Xizhi Technology with a subscription multiple of 2876 times, followed by Sunmi Technology with 286 times, and finally Maiwei Biotech with 133 times. I invested 1 million HKD, fully financed with a ratio of 5/2/3.

Xizhi Technology
Is working on a new approach to AI foundational computing power (optical computing + chips). Simply put, they want to replace traditional GPUs with faster and more energy-efficient methods. The story is big, but they are still in the money-burning stage, a typical high-volatility target of "AI trend + future-oriented talk."
Sunmi Technology
Specializes in selling smart devices (cash registers, barcode scanners, etc.) and system services to offline merchants like restaurants and retail stores. It is already a global leader, capable of making profits and generating cash flow. Essentially, it’s a steady and solid B2B business.
Maiwei Biotech
Focuses on innovative drugs, mainly anti-cancer and immunotherapy drugs. They already have products but are still investing heavily in R&D. Whether it’s worth money in the future depends entirely on whether the drugs can be successfully developed. It’s a typical "high risk and high uncertainty" pharmaceutical company.
Each spent 100 HKD on financing costs to scratch for a prize costing 300 HKD. Let’s see which one hits 😂